re 102 has been researched along with Graft vs Host Disease in 2 studies
*Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atsuta, Y; Doki, N; Fukuda, T; Ichinohe, T; Ishikawa, J; Kanda, Y; Kiyoi, H; Minami, Y; Mori, T; Murata, M; Nagamura-Inoue, T; Nishida, T; Shimazu, Y; Shirane, S; Suzuki, R; Tanaka, M; Togitani, K; Uchida, N | 1 |
| Aversa, F; Bunjes, D; Ciceri, F; Di Bartolomeo, P; Frassoni, F; Labopin, M; Lacerda, JF; Lewalle, P; Lupo Stanghellini, MT; Martelli, MF; Nagler, A; Polge, E; Rocha, V; Rowe, JM | 1 |
2 other study(ies) available for re 102 and Graft vs Host Disease
| Article | Year |
|---|---|
Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis.
Topics: Adult; Aged; Erythrocyte Transfusion; Female; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Morpholines; Platelet Transfusion; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Retrospective Studies; Survival Rate; Thrombocythemia, Essential; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 2020 |
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation.
Topics: Adolescent; Adult; Aged; Disease-Free Survival; Europe; Female; Graft Survival; Graft vs Host Disease; Haplotypes; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphocyte Transfusion; Male; Middle Aged; Morpholines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Risk Factors; Tissue Donors; Treatment Outcome | 2008 |